LIC MF Healthcare Fund-Regular Plan-Growth

arrow-up
NAV
₹ 28.3148 ₹ 0.17 (0.6 %)
as on 20-06-2025
Asset Size (AUM)
84.19 Cr
Launch Date
Feb 22, 2019
Investment Objective
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Minimum Investment 5000.0
Minimum Top-up 500.0
Investment Returns Since Launch in Feb 22, 2019
arrow-up

17.96

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.81 %
Expense Ratio
2.45%
Volatility
14.23 %
Fund House
LIC Mutual Fund
Fund Manager
Mr. Karan Doshi
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 5000.0 (plus in multiples of Rs. 500.0)

Entry Load
Not applicable
Exit Load
Nil, If units of the Scheme are redeemed or switched out up to 12% of the units (the limit) within 90 days from the date of allotment. 1% of the applicable NAV, If units of the scheme are redeemed or switched out in excess of the limit within 90 days from the date of allotment. Nil, If units of scheme are redeemed or switched out after 90 days from the date of allotment.
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquity
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFDGoldNifty
Fund₹ 11451
FD₹ 10600
Gold₹ 10800
Nifty₹ 11414
Performance

Scheme Performance (%)

Data as on - 20-06-2025
Created with Highcharts 4.1.4ReturnsLIC MF Healthcare Fund-Regular Plan-GrowthNIFTY Healthcare TRIEquity: Sectoral-Pharma and HealthcareYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-100102030

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesLIC MF Healthcare Fund-Regular Plan-GrowthNIFTY Healthcare TRIEquity: Sectoral-Pharma and Healthcare2016201720182019202020212022202320242025-20020406080
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund120,000119,942-58-0.11
Benchmark---
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 14.51 27.16 21.73 16.79 0.0
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 24.96 0.0 0.0 0.0 0.0
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth 06-02-2024 23.8 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 20.37 35.02 29.86 24.19 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 18.63 31.65 26.98 21.52 11.74
Portfolio Analysis
Portfolio as on 31-05-2025
Sector Allocation
SectorAllocation (%)
Healthcare88.29
Chemicals8.3
N/A3.41
Portfolio Holdings
CompanyHoldings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-10.73
CIPLA LIMITED EQ NEW FV RS.2/-5.43
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-4.95
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-4.84
Treps4.33
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-4.27
PIRAMAL PHARMA LIMITED EQ4.22
NEULAND LABORATORIES LIMITED EQ4.11
FORTIS HEALTHCARE LIMITED. EQ4
ALKEM LABORATORIES LIMITED EQ3.76
ARTEMIS MEDICARE SERVICES LIMITED EQ NEW FV Re.1/-3.61
ABBOTT INDIA LIMITED EQ3.5
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-3.48
VINATI ORGANICS LIMITED EQ NEW FV RE.1/-3.37
NAVIN FLUORINE INTERNATIONAL LTD EQ NEW FV RS. 2/-3.36
IPCA LABORATORIES LIMITED EQ NEW FV RE .1/-3.1
SYNGENE INTERNATIONAL LIMITED EQ3.02
JB Chemicals & Pharmaceuticals Limited2.94
CONCORD BIOTECH LIMITED EQ NEW FV RE.1/-2.56
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-2.51
Dr Agarwals Health Care Ltd. 2.42
METROPOLIS HEALTHCARE LIMITED EQ NEW FV RS. 2/-2.28
MAX HEALTHCARE INSTITUTE LIMITED EQ2.24
GLOBAL HEALTH LIMITED EQ2.11
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/-2.1
SUVEN PHARMACEUTICALS LIMITED EQ1.68
STELIS BIOPHARMA LIMITED EQ NEW FV RE.1/-1.67
ZYDUS LIFESCIENCES LIMITED EQ NEW FV RE. 1/-1.67
LINDE INDIA LIMITED EQ1.57
SANOFI CONSUMER HEALTHCARE INDIA LIMITED EQ1.09
Net Receivables / (Payables)-0.95
Sector Allocation
Created with Highcharts 4.1.4HealthcareOthers
Portfolio Holdings
Created with Highcharts 4.1.4SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-CIPLA LIMITED EQ NEW FV RS.2/-TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-TrepsAUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-PIRAMAL PHARMA LIMITED EQNEULAND LABORATORIES LIMITED EQFORTIS HEALTHCARE LIMITED. EQOthers